Table 4.
A) Women | ASCVD | ||||
---|---|---|---|---|---|
Risk Categoryc | Low Risk | Intermediate Low Risk | Intermediate High Risk | High Risk | |
Low risk | 2765 (49) | 74 (1) | 4 (< 1) | 0 (0) | |
QRISKII | Intermediate low risk | 603 (11) | 461 (8) | 195 (3) | 1 (< 1) |
Intermediate high risk | 70 (1) | 355 (6) | 498 (9) | 278 (5) | |
High risk | 7 (<1) | 20 (< 1) | 132 (2) | 227 (4) |
B) Men | ASCVD | ||||
---|---|---|---|---|---|
Risk Categoryc | Low Risk | Intermediate Low Risk | Intermediate High Risk | High Risk | |
Low risk | 559 (18) | 36 (1) | 0 (0) | 0 (0) | |
QRISKII | Intermediate low risk | 275 (9) | 342 (11) | 122 (4) | 0 (0) |
Intermediate high risk | 17 (< 1) | 243 (8) | 414 (13) | 333 (11) | |
High risk | 1 (< 1) | 12 (< 1) | 140 (5) | 599 (19) |
ASCVD atherosclerotic cardiovascular disease
Values are n (%)
Low risk ≤ 5%; Intermediate Low Risk 5% - ≤ 10%; Intermediate High Risk 10% - ≤ 20%; High Risk > 20%